Artificial Intelligence | Machine Learning Larimar Therapeutics | Developing Treatments for Complex Rare Diseases


Enterprise, Biotechnology, Medical, Therapeutics, Rare Disease, Drug Discovery, Clinical Trials Bala Cynwyd, PA, United States

Larimar Therapeutics

Artificial Intelligence | Machine Learning


Larimar Therapeutics | Developing Treatments for Complex Rare Diseases

Larimar Therapeutics

Biotechnology, Medical, Therapeutics, Rare Disease, Drug Discovery, Clinical Trials


Bala Cynwyd, PA, United States

Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease. Larimar Therapeutics also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

Larimar Therapeutics, based in the Philadelphia area, is committed to discovering and developing treatments for complex rare diseases, with an initial focus on Friedreich’s ataxia. Its proprietary protein replacement therapy platform is intended to deliver missing proteins inside the machinery of cells to treat devastating rare diseases that currently have ineffective or no treatments available.

 

B2B

26 to 50

Funded

$250.2 M

Scaling Up

2016

 
 

Medical Devices
Biotechnology

N/A

N/A

 
 

N/A

Yes

Active

 
 

   Machine Learning


Digital Therapeutics

Digital Therapeutics

Drug Discovery

Drug Discovery

Biotechnology

Biotechnology


N/A

 

   Software


N/A


Machine Learning Algorithm

Machine Learning Algorithm

 
 

View All

Associate Director, Bioanalytical Development

Bala Cynwyd, Pennsylvania

Neurobiology Scientist

Philadelphia, Pennsylvania

Drug Substance Manufacturing Specialist / Sr. Specialist

Bala Cynwyd, Pennsylvania

Specialist / Sr. Specialist Analytical Science

Bala Cynwyd, Pennsylvania

 

AI/ML Professionals

Want to work at Larimar Therapeutics?

We can introduce you to the right person at Larimar Therapeutics

Talk to our Talent Team

 

5

1

$95M

Company was founded 2016 and it took almost 5 years (May 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

05/21/2021

Funded

$95M

Vivo Capital, Verition Fund Management, RA Capital Management, Deerfield, Adage Capital Management

Date : 05/21/2021

Round: Funded

$ Raised: $95M

Investors: Vivo Capital, Verition Fund Management, RA Capital Management, Deerfield, Adage Capital Management

 

Investors

Interested in researching Larimar Therapeutics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Larimar Therapeutics

Request a Demo - Deal Souring Platform

 
Mike Celano


Mike Celano
Chief Financial Officer

Nancy M. Ruiz M.D.,FACP,FIDSA


Nancy M. Ruiz M.D.,FACP,FIDSA
Chief Medical Officer & Head Non-clinical Toxicology

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Larimar Therapeutics